Clinica BavieraXMAD:CBAV -0.36%99 FCF Yield % is 5.14 as of Jun. 28, 2026, which is 33% below its 10-year median of 7.70. GuruFocus rates XMAD:CBAV with a GF Score™ of 99/100 and a GF Value™ of €41.30 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Clinica Baviera ranks better than 81.78% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Clinica Baviera's FCF Yield % or its related term are showing as below:
XMAD:CBAV'
s FCF Yield % Range Over the Past 10 Years
Min: 1.12 Med: 7.7 Max: 16.03
Current: 5.14
During the past 13 years, the highest FCF Yield % of Clinica Baviera was 16.03%. The lowest was 1.12%. And the median was 7.70%.
XMAD:CBAV's FCF Yield % is ranked better than 81.78% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.455
vs XMAD:CBAV: 5.14
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Clinica Baviera FCF Yield % Related Terms
Clinica Baviera FCF Yield % Historical Data
* Premium members only.
The historical data trend for Clinica Baviera's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:CBAV vs TMO, DHR, IDXX: FCF Yield % Comparison
For the Diagnostics & Research subindustry, Clinica Baviera's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinica Baviera FCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Clinica Baviera's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinica Baviera (XMAD:CBAV) has a FCF Yield % of 5.14 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Clinica Baviera and its competitors. This is 33% below median its historical median of 7.70. Over the past decade, Clinica Baviera's FCF Yield % has ranged from 1.12 to 16.03. According to the industry distribution chart, Clinica Baviera ranks #39 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 18.2%.
Is Clinica Baviera's FCF Yield % too high?
Clinica Baviera's current FCF Yield % of 5.14 is 33% below median its 10-year median of 7.70. Over the past 10 years, this metric has ranged from a low of 1.12 to a high of 16.03. Based on the distribution chart, Clinica Baviera ranks #39 out of 214 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Clinica Baviera has a GF Score™ of 99/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's FCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clinica Baviera ranks #39 out of 214 companies for FCF Yield %. This places Clinica Baviera in the top 18% of its industry — outperforming the majority of peers. Historically, Clinica Baviera's own FCF Yield % has ranged from 1.12 to 16.03 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Clinica Baviera and its competitors. Clinica Baviera's current FCF Yield % is 5.14, which is 33% below median its own 10-year median of 7.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Based on GuruFocus' analysis, Clinica Baviera (XMAD:CBAV) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.30, compared to a current price of €55.20 — trading 33.7% above its estimated fair value. The current FCF Yield % is 5.14, which is 33% below median its 10-year median of 7.70. Clinica Baviera's overall GF Score™ is 99/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Clinica Baviera (XMAD:CBAV), the current FCF Yield % is 5.14 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?
Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued.
The current stock price of €55.20 is trading 33.7% above its estimated GF Value™ of €41.30.
GuruFocus considers Clinica Baviera to be Significantly Overvalued.
Key valuation signals for XMAD:CBAV:
FCF Yield %: 5.14 (33% below median its 10-year median of 7.70)
GF Value™: €41.30 vs. price of €55.20 (33.7% above fair value)
No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
99GF Score
Get the complete analysis for XMAD:CBAV
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:CBAV has been successfully added to your 
